Induction of mucosal immunity by pulmonary administration of a cell-targeting nanoparticle

被引：4

作者：

Kurosaki, Tomoaki ^{[1
,2
]}

Katafuchi, Yuki ^{[2
]}

Hashizume, Junya ^{[1
]}

Harasawa, Hitomi ^{[1
]}

Nakagawa, Hiroo ^{[1
]}

Nakashima, Mikiro ^{[2
]}

Nakamura, Tadahiro ^{[1
]}

Yamashita, Chikamasa ^{[3
]}

Sasaki, Hitoshi ^{[1
,2
]}

Kodama, Yukinobu ^{[1
]}

机构：

[1] Nagasaki Univ Hosp, Dept Hosp Pharm, 1-7-1 Sakamoto, Nagasaki 8528501, Japan

[2] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki, Japan

[3] Tokyo Univ Sci, Fac Pharmaceut Sci, Chiba, Japan

来源：

DRUG DELIVERY | 2021年 / 28卷 / 01期

基金：

日本学术振兴会;

关键词：

Vaccine; pulmonary administration; nanoparticles; gamma-polyglutamic acid; mucosal immunity; VACCINE; INTRANASAL; ANTIBODIES; DELIVERY; ACID;

D O I：

10.1080/10717544.2021.1955040

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

We previously found that a nanoparticle constructed with an antigen, benzalkonium chloride (BK) and gamma-polyglutamic acid (gamma-PGA) showed high Th1 and Th2-type immune induction after subcutaneous administration. For prophylaxis of respiratory infections, however, mucosal immunity should be induced. In this study, we investigated the effect of pulmonary administration of a nanoparticle comprising ovalbumin (OVA) as a model antigen, BK, and gamma-PGA on induction of mucosal immunity in the lungs and serum. The complex was strongly taken up by RAW264.7 and DC2.4cells. After pulmonary administration, lung retention was longer for the OVA/BK/gamma-PGA complex than for OVA alone. OVA-specific serum immunoglobulin (Ig)G was highly induced by the complex. High IgG and IgA levels were also induced in the bronchoalveolar lavage fluid, and in vivo toxicities were not observed. In conclusion, we effectively and safely induced mucosal immunity by pulmonary administration of an OVA/BK/gamma-PGA complex.

引用

页码：1585 / 1593

页数：9

共 50 条

[21] Covalent conjugation of oligonucleotides with cell-targeting ligands
Alam, Md. Rowshon
Ming, Xin
Nakagawa, Osamu
Jin, Jian
Juliano, R. L.
BIOORGANIC & MEDICINAL CHEMISTRY, 2013, 21 (20) : 6217 - 6223
[22] Establishment of cancer stem cell-targeting immunotherapy
Hirohashi, Yoshihiko
Torigoe, Toshihiko
Morita, Rena
Sato, Noriyuki
ANNALS OF ONCOLOGY, 2015, 26 : 31 - 31
[23] Polypyrrole nanospheres with magnetic and cell-targeting capabilities
Wuang, Shy Chyi
Neoh, Koon Gee
Kang, En-Tang
Pack, Daniel W.
Leckband, Deborah E.
MACROMOLECULAR RAPID COMMUNICATIONS, 2007, 28 (07) : 816 - 821
[24] Cytokines as adjuvants for the induction of mucosal immunity
Boyaka, PN
McGhee, JR
ADVANCED DRUG DELIVERY REVIEWS, 2001, 51 (1-3) : 71 - 79
[25] Clickable modular polysaccharide nanoparticles for selective cell-targeting
Peuler, Kevin
Dimmitt, Nathan
Lin, Chien-Chi
CARBOHYDRATE POLYMERS, 2020, 234
[26] Inducing immune tolerance with dendritic cell-targeting nanomedicines
Anna Cifuentes-Rius
Anal Desai
Daniel Yuen
Angus P. R. Johnston
Nicolas H. Voelcker
Nature Nanotechnology, 2021, 16 : 37 - 46
[27] Cell-penetrating and cell-targeting peptides in drug delivery
Vives, Eric
Schmidt, Julien
Pelegrin, Andre
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2008, 1786 (02): : 126 - 138
[28] Mast Cell-Targeting Therapies in Mast Cell Activation Syndromes
Sabato, Vito
Beyens, Michiel
Toscano, Alessandro
Van Gasse, Athina
Ebo, Didier G.
CURRENT ALLERGY AND ASTHMA REPORTS, 2024, 24 (02) : 63 - 71
[29] CELL-TARGETING FUSION CONSTRUCTS CONTAINING RECOMBINANT GELONIN
Lyu, Mi-Ae
Cao, Yu
Mohamedali, Khalid A.
Rosenblum, Michael G.
METHODS IN ENZYMOLOGY, VOL 502: PROTEIN ENGINEERING FOR THERAPEUTICS, PT A, 2012, 502 : 167 - 214
[30] Cell-targeting aptamers act as intracellular delivery vehicles
Gopinath, Subash C. B.
Lakshmipriya, Thangavel
Chen, Yeng
Arshad, M. K. Md
Kerishnan, Jesinda P.
Ruslinda, A. R.
Al-Douri, Y.
Voon, C. H.
Hashim, Uda
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2016, 100 (16) : 6955 - 6969

← 1 2 3 4 5 →